Prestige Consumer Healthcare
237 hedge funds and large institutions have $1.83B invested in Prestige Consumer Healthcare in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 76 increasing their positions, 97 reducing their positions, and 33 closing their positions.
30% more call options, than puts
Call options by funds: $1.22M | Put options by funds: $945K
1.58% less ownership
Funds ownership: 106.43% → 104.86% (-1.6%)
2% less funds holding
Funds holding: 242 → 237 (-5)
6% less capital invested
Capital invested by funds: $1.94B → $1.83B (-$112M)
15% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 33
22% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 97
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCAM
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
+$62.2M |
| 2 |
BlackRock
New York
|
+$12M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$11.6M |
| 4 |
Morgan Stanley
New York
|
+$5.43M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$4.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.8M |
| 2 |
JP Morgan Chase
New York
|
-$22.1M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$13.6M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$12.5M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$8.43M |
PBH Hedge Fund Activity: Q4 2020 in Review
237 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2020, worth a combined $1.83B — down 5.8% from $1.94B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of PBH and 28 opened new positions — a net loss of 5 holders — while 97 trimmed existing stakes and 76 added.
The largest buyer was Turtle Creek Asset Management, adding an estimated $62.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $23.8M.
- 237 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2020, down from 242 in Q3 2020.
- Funds reported $1.83B of Prestige Consumer Healthcare stock for Q4 2020, down 5.8% quarter-over-quarter.
- 28 funds opened new Prestige Consumer Healthcare positions in Q4 2020 and 33 closed out, a net change of -5 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2020 was Turtle Creek Asset Management, an estimated $62.2M added.
- The largest Prestige Consumer Healthcare seller in Q4 2020 was T. Rowe Price Associates, an estimated $23.8M sold.
Based on aggregated 13F filings for Q4 2020.